nodes	percent_of_prediction	percent_of_DWPC	metapath
Clarithromycin—CYP1A2—Carmustine—malignant glioma	0.349	0.569	CbGbCtD
Clarithromycin—CYP3A4—Temozolomide—malignant glioma	0.263	0.43	CbGbCtD
Clarithromycin—Abnormal behaviour—Temozolomide—malignant glioma	0.00859	0.0304	CcSEcCtD
Clarithromycin—Tongue discolouration—Temozolomide—malignant glioma	0.00662	0.0235	CcSEcCtD
Clarithromycin—Oral candidiasis—Carmustine—malignant glioma	0.00521	0.0185	CcSEcCtD
Clarithromycin—Oral candidiasis—Temozolomide—malignant glioma	0.00504	0.0179	CcSEcCtD
Clarithromycin—Cyst—Carmustine—malignant glioma	0.00495	0.0176	CcSEcCtD
Clarithromycin—Parosmia—Temozolomide—malignant glioma	0.00493	0.0175	CcSEcCtD
Clarithromycin—Troleandomycin—CYP2C18—malignant glioma	0.00481	0.383	CrCbGaD
Clarithromycin—Roxithromycin—CYP2B6—malignant glioma	0.00465	0.37	CrCbGaD
Clarithromycin—Myopathy—Temozolomide—malignant glioma	0.00456	0.0162	CcSEcCtD
Clarithromycin—Hepatotoxicity—Carmustine—malignant glioma	0.00429	0.0152	CcSEcCtD
Clarithromycin—Cholestasis—Temozolomide—malignant glioma	0.00421	0.0149	CcSEcCtD
Clarithromycin—Hepatotoxicity—Temozolomide—malignant glioma	0.00414	0.0147	CcSEcCtD
Clarithromycin—Otitis media—Temozolomide—malignant glioma	0.00411	0.0146	CcSEcCtD
Clarithromycin—Gamma-glutamyltransferase increased—Temozolomide—malignant glioma	0.00389	0.0138	CcSEcCtD
Clarithromycin—Accidental injury—Carmustine—malignant glioma	0.00374	0.0133	CcSEcCtD
Clarithromycin—Drug interaction—Carmustine—malignant glioma	0.00357	0.0127	CcSEcCtD
Clarithromycin—Hearing impaired—Temozolomide—malignant glioma	0.00336	0.0119	CcSEcCtD
Clarithromycin—Pulmonary embolism—Carmustine—malignant glioma	0.00331	0.0117	CcSEcCtD
Clarithromycin—Pulmonary embolism—Temozolomide—malignant glioma	0.0032	0.0113	CcSEcCtD
Clarithromycin—Candida infection—Carmustine—malignant glioma	0.00316	0.0112	CcSEcCtD
Clarithromycin—Erythromycin—CYP2B6—malignant glioma	0.0031	0.247	CrCbGaD
Clarithromycin—Candida infection—Temozolomide—malignant glioma	0.00306	0.0108	CcSEcCtD
Clarithromycin—Vaginal infection—Temozolomide—malignant glioma	0.00302	0.0107	CcSEcCtD
Clarithromycin—Neoplasm—Carmustine—malignant glioma	0.00299	0.0106	CcSEcCtD
Clarithromycin—Neoplasm—Temozolomide—malignant glioma	0.00289	0.0103	CcSEcCtD
Clarithromycin—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.00267	0.00946	CcSEcCtD
Clarithromycin—Gastroenteritis—Temozolomide—malignant glioma	0.00262	0.00929	CcSEcCtD
Clarithromycin—Injury—Carmustine—malignant glioma	0.00262	0.00927	CcSEcCtD
Clarithromycin—Deafness—Temozolomide—malignant glioma	0.0026	0.0092	CcSEcCtD
Clarithromycin—Hepatic failure—Temozolomide—malignant glioma	0.00258	0.00916	CcSEcCtD
Clarithromycin—Purpura—Temozolomide—malignant glioma	0.00241	0.00854	CcSEcCtD
Clarithromycin—Liver function test abnormal—Carmustine—malignant glioma	0.00222	0.00786	CcSEcCtD
Clarithromycin—Breast disorder—Temozolomide—malignant glioma	0.0021	0.00744	CcSEcCtD
Clarithromycin—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.00209	0.00741	CcSEcCtD
Clarithromycin—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00209	0.00741	CcSEcCtD
Clarithromycin—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00205	0.00726	CcSEcCtD
Clarithromycin—Abdominal distension—Temozolomide—malignant glioma	0.00202	0.00716	CcSEcCtD
Clarithromycin—Neutropenia—Carmustine—malignant glioma	0.00194	0.00688	CcSEcCtD
Clarithromycin—Dysuria—Temozolomide—malignant glioma	0.00188	0.00665	CcSEcCtD
Clarithromycin—Neutropenia—Temozolomide—malignant glioma	0.00188	0.00665	CcSEcCtD
Clarithromycin—Pneumonia—Carmustine—malignant glioma	0.00186	0.0066	CcSEcCtD
Clarithromycin—Depression—Carmustine—malignant glioma	0.00185	0.00655	CcSEcCtD
Clarithromycin—Renal failure—Carmustine—malignant glioma	0.00182	0.00645	CcSEcCtD
Clarithromycin—Stomatitis—Carmustine—malignant glioma	0.00181	0.0064	CcSEcCtD
Clarithromycin—Pneumonia—Temozolomide—malignant glioma	0.0018	0.00638	CcSEcCtD
Clarithromycin—Infestation—Temozolomide—malignant glioma	0.00179	0.00634	CcSEcCtD
Clarithromycin—Infestation NOS—Temozolomide—malignant glioma	0.00179	0.00634	CcSEcCtD
Clarithromycin—Depression—Temozolomide—malignant glioma	0.00179	0.00633	CcSEcCtD
Clarithromycin—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00177	0.00629	CcSEcCtD
Clarithromycin—Stomatitis—Temozolomide—malignant glioma	0.00174	0.00618	CcSEcCtD
Clarithromycin—Hepatobiliary disease—Temozolomide—malignant glioma	0.00169	0.006	CcSEcCtD
Clarithromycin—Haemoglobin—Carmustine—malignant glioma	0.00167	0.00592	CcSEcCtD
Clarithromycin—Haemorrhage—Carmustine—malignant glioma	0.00166	0.00589	CcSEcCtD
Clarithromycin—Hallucination—Carmustine—malignant glioma	0.00165	0.00586	CcSEcCtD
Clarithromycin—Connective tissue disorder—Carmustine—malignant glioma	0.00163	0.00579	CcSEcCtD
Clarithromycin—Haemoglobin—Temozolomide—malignant glioma	0.00162	0.00572	CcSEcCtD
Clarithromycin—Hepatitis—Temozolomide—malignant glioma	0.00161	0.00569	CcSEcCtD
Clarithromycin—Haemorrhage—Temozolomide—malignant glioma	0.00161	0.00569	CcSEcCtD
Clarithromycin—Visual impairment—Carmustine—malignant glioma	0.0016	0.00568	CcSEcCtD
Clarithromycin—Hallucination—Temozolomide—malignant glioma	0.0016	0.00567	CcSEcCtD
Clarithromycin—Pharyngitis—Temozolomide—malignant glioma	0.0016	0.00565	CcSEcCtD
Clarithromycin—Urinary tract disorder—Temozolomide—malignant glioma	0.00159	0.00562	CcSEcCtD
Clarithromycin—Connective tissue disorder—Temozolomide—malignant glioma	0.00158	0.0056	CcSEcCtD
Clarithromycin—Urethral disorder—Temozolomide—malignant glioma	0.00158	0.00558	CcSEcCtD
Clarithromycin—Eye disorder—Carmustine—malignant glioma	0.00155	0.00551	CcSEcCtD
Clarithromycin—Visual impairment—Temozolomide—malignant glioma	0.00155	0.00549	CcSEcCtD
Clarithromycin—Flushing—Carmustine—malignant glioma	0.00154	0.00547	CcSEcCtD
Clarithromycin—Erythema multiforme—Temozolomide—malignant glioma	0.00152	0.00538	CcSEcCtD
Clarithromycin—Eye disorder—Temozolomide—malignant glioma	0.0015	0.00532	CcSEcCtD
Clarithromycin—Tinnitus—Temozolomide—malignant glioma	0.0015	0.00531	CcSEcCtD
Clarithromycin—Flushing—Temozolomide—malignant glioma	0.00149	0.00529	CcSEcCtD
Clarithromycin—Cardiac disorder—Temozolomide—malignant glioma	0.00149	0.00529	CcSEcCtD
Clarithromycin—Angiopathy—Temozolomide—malignant glioma	0.00146	0.00517	CcSEcCtD
Clarithromycin—Mental disorder—Carmustine—malignant glioma	0.00146	0.00516	CcSEcCtD
Clarithromycin—Immune system disorder—Temozolomide—malignant glioma	0.00145	0.00514	CcSEcCtD
Clarithromycin—Mediastinal disorder—Temozolomide—malignant glioma	0.00145	0.00513	CcSEcCtD
Clarithromycin—Malnutrition—Carmustine—malignant glioma	0.00145	0.00513	CcSEcCtD
Clarithromycin—Chills—Temozolomide—malignant glioma	0.00144	0.00511	CcSEcCtD
Clarithromycin—Mental disorder—Temozolomide—malignant glioma	0.00141	0.00499	CcSEcCtD
Clarithromycin—Back pain—Carmustine—malignant glioma	0.0014	0.00496	CcSEcCtD
Clarithromycin—Malnutrition—Temozolomide—malignant glioma	0.0014	0.00496	CcSEcCtD
Clarithromycin—Dysgeusia—Temozolomide—malignant glioma	0.00137	0.00485	CcSEcCtD
Clarithromycin—Tremor—Carmustine—malignant glioma	0.00136	0.00481	CcSEcCtD
Clarithromycin—Back pain—Temozolomide—malignant glioma	0.00135	0.0048	CcSEcCtD
Clarithromycin—Anaemia—Carmustine—malignant glioma	0.00134	0.00474	CcSEcCtD
Clarithromycin—Agitation—Carmustine—malignant glioma	0.00133	0.00471	CcSEcCtD
Clarithromycin—Tremor—Temozolomide—malignant glioma	0.00131	0.00464	CcSEcCtD
Clarithromycin—Ill-defined disorder—Temozolomide—malignant glioma	0.0013	0.0046	CcSEcCtD
Clarithromycin—Leukopenia—Carmustine—malignant glioma	0.0013	0.00459	CcSEcCtD
Clarithromycin—Anaemia—Temozolomide—malignant glioma	0.00129	0.00458	CcSEcCtD
Clarithromycin—Agitation—Temozolomide—malignant glioma	0.00129	0.00456	CcSEcCtD
Clarithromycin—Angioedema—Temozolomide—malignant glioma	0.00128	0.00453	CcSEcCtD
Clarithromycin—Malaise—Temozolomide—malignant glioma	0.00126	0.00447	CcSEcCtD
Clarithromycin—Vertigo—Temozolomide—malignant glioma	0.00126	0.00445	CcSEcCtD
Clarithromycin—Convulsion—Carmustine—malignant glioma	0.00125	0.00444	CcSEcCtD
Clarithromycin—Leukopenia—Temozolomide—malignant glioma	0.00125	0.00444	CcSEcCtD
Clarithromycin—Palpitations—Temozolomide—malignant glioma	0.00124	0.00438	CcSEcCtD
Clarithromycin—Myalgia—Carmustine—malignant glioma	0.00123	0.00437	CcSEcCtD
Clarithromycin—Chest pain—Carmustine—malignant glioma	0.00123	0.00437	CcSEcCtD
Clarithromycin—Anxiety—Carmustine—malignant glioma	0.00123	0.00435	CcSEcCtD
Clarithromycin—Cough—Temozolomide—malignant glioma	0.00122	0.00433	CcSEcCtD
Clarithromycin—Convulsion—Temozolomide—malignant glioma	0.00121	0.0043	CcSEcCtD
Clarithromycin—Confusional state—Carmustine—malignant glioma	0.00119	0.00422	CcSEcCtD
Clarithromycin—Myalgia—Temozolomide—malignant glioma	0.00119	0.00422	CcSEcCtD
Clarithromycin—Anxiety—Temozolomide—malignant glioma	0.00119	0.00421	CcSEcCtD
Clarithromycin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00118	0.00419	CcSEcCtD
Clarithromycin—Discomfort—Temozolomide—malignant glioma	0.00118	0.00417	CcSEcCtD
Clarithromycin—Infection—Carmustine—malignant glioma	0.00117	0.00416	CcSEcCtD
Clarithromycin—Dry mouth—Temozolomide—malignant glioma	0.00116	0.00413	CcSEcCtD
Clarithromycin—Thrombocytopenia—Carmustine—malignant glioma	0.00116	0.0041	CcSEcCtD
Clarithromycin—Confusional state—Temozolomide—malignant glioma	0.00115	0.00408	CcSEcCtD
Clarithromycin—Anaphylactic shock—Temozolomide—malignant glioma	0.00114	0.00405	CcSEcCtD
Clarithromycin—Infection—Temozolomide—malignant glioma	0.00113	0.00402	CcSEcCtD
Clarithromycin—Anorexia—Carmustine—malignant glioma	0.00113	0.00399	CcSEcCtD
Clarithromycin—Nervous system disorder—Temozolomide—malignant glioma	0.00112	0.00397	CcSEcCtD
Clarithromycin—Thrombocytopenia—Temozolomide—malignant glioma	0.00112	0.00396	CcSEcCtD
Clarithromycin—Skin disorder—Temozolomide—malignant glioma	0.00111	0.00393	CcSEcCtD
Clarithromycin—Hyperhidrosis—Temozolomide—malignant glioma	0.0011	0.00391	CcSEcCtD
Clarithromycin—Anorexia—Temozolomide—malignant glioma	0.00109	0.00386	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00108	0.00381	CcSEcCtD
Clarithromycin—Insomnia—Carmustine—malignant glioma	0.00107	0.00379	CcSEcCtD
Clarithromycin—Paraesthesia—Carmustine—malignant glioma	0.00106	0.00376	CcSEcCtD
Clarithromycin—Dyspnoea—Carmustine—malignant glioma	0.00105	0.00373	CcSEcCtD
Clarithromycin—Somnolence—Carmustine—malignant glioma	0.00105	0.00372	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00104	0.00369	CcSEcCtD
Clarithromycin—Insomnia—Temozolomide—malignant glioma	0.00103	0.00366	CcSEcCtD
Clarithromycin—Decreased appetite—Carmustine—malignant glioma	0.00103	0.00364	CcSEcCtD
Clarithromycin—Paraesthesia—Temozolomide—malignant glioma	0.00103	0.00363	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Carmustine—malignant glioma	0.00102	0.00361	CcSEcCtD
Clarithromycin—Dyspnoea—Temozolomide—malignant glioma	0.00102	0.00361	CcSEcCtD
Clarithromycin—Somnolence—Temozolomide—malignant glioma	0.00102	0.0036	CcSEcCtD
Clarithromycin—Pain—Carmustine—malignant glioma	0.00101	0.00358	CcSEcCtD
Clarithromycin—Constipation—Carmustine—malignant glioma	0.00101	0.00358	CcSEcCtD
Clarithromycin—Dyspepsia—Temozolomide—malignant glioma	0.00101	0.00356	CcSEcCtD
Clarithromycin—Decreased appetite—Temozolomide—malignant glioma	0.000993	0.00352	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000986	0.00349	CcSEcCtD
Clarithromycin—Fatigue—Temozolomide—malignant glioma	0.000984	0.00349	CcSEcCtD
Clarithromycin—Constipation—Temozolomide—malignant glioma	0.000976	0.00346	CcSEcCtD
Clarithromycin—Pain—Temozolomide—malignant glioma	0.000976	0.00346	CcSEcCtD
Clarithromycin—Feeling abnormal—Carmustine—malignant glioma	0.000974	0.00345	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Carmustine—malignant glioma	0.000966	0.00342	CcSEcCtD
Clarithromycin—Feeling abnormal—Temozolomide—malignant glioma	0.000941	0.00333	CcSEcCtD
Clarithromycin—Body temperature increased—Carmustine—malignant glioma	0.000934	0.00331	CcSEcCtD
Clarithromycin—Abdominal pain—Carmustine—malignant glioma	0.000934	0.00331	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Temozolomide—malignant glioma	0.000934	0.00331	CcSEcCtD
Clarithromycin—Urticaria—Temozolomide—malignant glioma	0.000907	0.00321	CcSEcCtD
Clarithromycin—Abdominal pain—Temozolomide—malignant glioma	0.000903	0.0032	CcSEcCtD
Clarithromycin—Body temperature increased—Temozolomide—malignant glioma	0.000903	0.0032	CcSEcCtD
Clarithromycin—Hypersensitivity—Carmustine—malignant glioma	0.00087	0.00308	CcSEcCtD
Clarithromycin—Asthenia—Carmustine—malignant glioma	0.000848	0.003	CcSEcCtD
Clarithromycin—Hypersensitivity—Temozolomide—malignant glioma	0.000841	0.00298	CcSEcCtD
Clarithromycin—Asthenia—Temozolomide—malignant glioma	0.000819	0.0029	CcSEcCtD
Clarithromycin—Diarrhoea—Carmustine—malignant glioma	0.000808	0.00286	CcSEcCtD
Clarithromycin—Pruritus—Temozolomide—malignant glioma	0.000808	0.00286	CcSEcCtD
Clarithromycin—Dizziness—Carmustine—malignant glioma	0.000781	0.00277	CcSEcCtD
Clarithromycin—Diarrhoea—Temozolomide—malignant glioma	0.000781	0.00277	CcSEcCtD
Clarithromycin—Dizziness—Temozolomide—malignant glioma	0.000755	0.00268	CcSEcCtD
Clarithromycin—Vomiting—Carmustine—malignant glioma	0.000751	0.00266	CcSEcCtD
Clarithromycin—Rash—Carmustine—malignant glioma	0.000745	0.00264	CcSEcCtD
Clarithromycin—Dermatitis—Carmustine—malignant glioma	0.000744	0.00264	CcSEcCtD
Clarithromycin—Headache—Carmustine—malignant glioma	0.00074	0.00262	CcSEcCtD
Clarithromycin—Vomiting—Temozolomide—malignant glioma	0.000726	0.00257	CcSEcCtD
Clarithromycin—Rash—Temozolomide—malignant glioma	0.00072	0.00255	CcSEcCtD
Clarithromycin—Dermatitis—Temozolomide—malignant glioma	0.000719	0.00255	CcSEcCtD
Clarithromycin—Headache—Temozolomide—malignant glioma	0.000715	0.00253	CcSEcCtD
Clarithromycin—Nausea—Carmustine—malignant glioma	0.000702	0.00249	CcSEcCtD
Clarithromycin—Nausea—Temozolomide—malignant glioma	0.000678	0.0024	CcSEcCtD
Clarithromycin—CYP3A5—Biological oxidations—GSTP1—malignant glioma	0.000146	0.00156	CbGpPWpGaD
Clarithromycin—CYP3A5—Metapathway biotransformation—GSTP1—malignant glioma	0.000144	0.00154	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—CD80—malignant glioma	0.00014	0.0015	CbGpPWpGaD
Clarithromycin—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	0.000139	0.0015	CbGpPWpGaD
Clarithromycin—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	0.000137	0.00148	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—malignant glioma	0.000137	0.00147	CbGpPWpGaD
Clarithromycin—ABCB1—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000136	0.00146	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—malignant glioma	0.000136	0.00146	CbGpPWpGaD
Clarithromycin—CYP1A2—Tryptophan metabolism—MDM2—malignant glioma	0.000135	0.00145	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—malignant glioma	0.000135	0.00145	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—malignant glioma	0.000131	0.0014	CbGpPWpGaD
Clarithromycin—CYP1A2—Biological oxidations—GSTT1—malignant glioma	0.000127	0.00136	CbGpPWpGaD
Clarithromycin—ABCB1—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000125	0.00134	CbGpPWpGaD
Clarithromycin—CYP1A2—Arachidonic acid metabolism—PTGS2—malignant glioma	0.000122	0.00131	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—malignant glioma	0.000122	0.0013	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—malignant glioma	0.000121	0.0013	CbGpPWpGaD
Clarithromycin—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	0.000121	0.0013	CbGpPWpGaD
Clarithromycin—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	0.000119	0.00128	CbGpPWpGaD
Clarithromycin—CYP1A2—Biological oxidations—PTGS1—malignant glioma	0.000119	0.00127	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—COX8A—malignant glioma	0.000117	0.00126	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—RTEL1—malignant glioma	0.000114	0.00122	CbGpPWpGaD
Clarithromycin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—malignant glioma	0.000113	0.00121	CbGpPWpGaD
Clarithromycin—CYP2C19—Biological oxidations—GSTP1—malignant glioma	0.000113	0.00121	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—RTEL1—malignant glioma	0.000111	0.00119	CbGpPWpGaD
Clarithromycin—CYP2C19—Metapathway biotransformation—GSTP1—malignant glioma	0.000111	0.00119	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—IFNG—malignant glioma	0.000111	0.00119	CbGpPWpGaD
Clarithromycin—ABCB1—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000109	0.00117	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	0.000106	0.00114	CbGpPWpGaD
Clarithromycin—ABCB1—Transmembrane transport of small molecules—APOD—malignant glioma	0.000106	0.00114	CbGpPWpGaD
Clarithromycin—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	0.000105	0.00112	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—CXCL8—malignant glioma	0.000103	0.00111	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—malignant glioma	0.000103	0.0011	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—ASMT—malignant glioma	9.95e-05	0.00107	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	9.88e-05	0.00106	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—IL1B—malignant glioma	9.88e-05	0.00106	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—CASP3—malignant glioma	9.85e-05	0.00106	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—IL2—malignant glioma	9.84e-05	0.00106	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	9.8e-05	0.00105	CbGpPWpGaD
Clarithromycin—CYP3A4—Biological oxidations—GSTT1—malignant glioma	9.77e-05	0.00105	CbGpPWpGaD
Clarithromycin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—malignant glioma	9.66e-05	0.00104	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—malignant glioma	9.47e-05	0.00102	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—BCAN—malignant glioma	9.36e-05	0.001	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—malignant glioma	9.26e-05	0.000994	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—malignant glioma	9.26e-05	0.000994	CbGpPWpGaD
Clarithromycin—CYP3A4—Biological oxidations—PTGS1—malignant glioma	9.16e-05	0.000983	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	8.9e-05	0.000955	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—RTEL1—malignant glioma	8.88e-05	0.000953	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—malignant glioma	8.82e-05	0.000947	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—malignant glioma	8.82e-05	0.000947	CbGpPWpGaD
Clarithromycin—CYP1A2—Biological oxidations—GSTP1—malignant glioma	8.78e-05	0.000942	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—malignant glioma	8.75e-05	0.000939	CbGpPWpGaD
Clarithromycin—CYP1A2—Metapathway biotransformation—GSTP1—malignant glioma	8.66e-05	0.000929	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—COX8A—malignant glioma	8.46e-05	0.000909	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—VEGFA—malignant glioma	8.36e-05	0.000898	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	8.14e-05	0.000874	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	7.95e-05	0.000854	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	7.88e-05	0.000846	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—IDH2—malignant glioma	7.54e-05	0.00081	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—ASMT—malignant glioma	7.2e-05	0.000773	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—TNF—malignant glioma	7.17e-05	0.000769	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	7.12e-05	0.000765	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—CYP2B6—malignant glioma	7.09e-05	0.000762	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	6.9e-05	0.000741	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—RTEL1—malignant glioma	6.85e-05	0.000735	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	6.82e-05	0.000732	CbGpPWpGaD
Clarithromycin—CYP3A4—Biological oxidations—GSTP1—malignant glioma	6.77e-05	0.000727	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—BCAN—malignant glioma	6.77e-05	0.000726	CbGpPWpGaD
Clarithromycin—SLC22A7—Transmembrane transport of small molecules—RAF1—malignant glioma	6.73e-05	0.000723	CbGpPWpGaD
Clarithromycin—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	6.68e-05	0.000717	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—COX8A—malignant glioma	6.54e-05	0.000702	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—IDH1—malignant glioma	6.49e-05	0.000696	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—COX8A—malignant glioma	6.39e-05	0.000686	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	6.34e-05	0.000681	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—SPHK1—malignant glioma	6.28e-05	0.000674	CbGpPWpGaD
Clarithromycin—ABCB1—HIF-1-alpha transcription factor network—AKT1—malignant glioma	6.16e-05	0.000661	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—CYP2C18—malignant glioma	6.15e-05	0.00066	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	6.14e-05	0.000659	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	5.85e-05	0.000628	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	5.81e-05	0.000624	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—ASMT—malignant glioma	5.56e-05	0.000597	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	5.51e-05	0.000592	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—IDH2—malignant glioma	5.45e-05	0.000585	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	5.44e-05	0.000584	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	5.43e-05	0.000583	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—ASMT—malignant glioma	5.43e-05	0.000583	CbGpPWpGaD
Clarithromycin—ABCB1—Transmembrane transport of small molecules—TFRC—malignant glioma	5.43e-05	0.000583	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	5.42e-05	0.000581	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	5.36e-05	0.000575	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	5.24e-05	0.000562	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—BCAN—malignant glioma	5.23e-05	0.000562	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—CYP2B6—malignant glioma	5.13e-05	0.00055	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—BCAN—malignant glioma	5.11e-05	0.000548	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—COX8A—malignant glioma	5.1e-05	0.000547	CbGpPWpGaD
Clarithromycin—ABCB1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	4.98e-05	0.000535	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—GSTT1—malignant glioma	4.97e-05	0.000534	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	4.86e-05	0.000522	CbGpPWpGaD
Clarithromycin—ABCB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	4.74e-05	0.000509	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—IDH1—malignant glioma	4.69e-05	0.000503	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—PTGS1—malignant glioma	4.66e-05	0.0005	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	4.57e-05	0.00049	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	4.56e-05	0.000489	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—SPHK1—malignant glioma	4.54e-05	0.000487	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—CYP2C18—malignant glioma	4.45e-05	0.000477	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—ASMT—malignant glioma	4.33e-05	0.000465	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—BCHE—malignant glioma	4.33e-05	0.000465	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—SLC5A5—malignant glioma	4.28e-05	0.000459	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	4.24e-05	0.000455	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—IDH2—malignant glioma	4.22e-05	0.000453	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	4.13e-05	0.000443	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—IDH2—malignant glioma	4.12e-05	0.000442	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—BCAN—malignant glioma	4.08e-05	0.000438	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.98e-05	0.000427	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—CYP2B6—malignant glioma	3.96e-05	0.000426	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—COX8A—malignant glioma	3.93e-05	0.000422	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—CYP2B6—malignant glioma	3.87e-05	0.000415	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	3.8e-05	0.000408	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	3.71e-05	0.000399	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—IDH1—malignant glioma	3.63e-05	0.000389	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—GSTT1—malignant glioma	3.6e-05	0.000386	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—IDH1—malignant glioma	3.54e-05	0.00038	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	3.54e-05	0.00038	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	3.51e-05	0.000377	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—SPHK1—malignant glioma	3.51e-05	0.000377	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—GSTP1—malignant glioma	3.45e-05	0.00037	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—CYP2C18—malignant glioma	3.44e-05	0.000369	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—SPHK1—malignant glioma	3.42e-05	0.000368	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—PTGS1—malignant glioma	3.37e-05	0.000362	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—CAT—malignant glioma	3.35e-05	0.00036	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—CYP2C18—malignant glioma	3.35e-05	0.00036	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—ASMT—malignant glioma	3.35e-05	0.000359	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—IDH2—malignant glioma	3.29e-05	0.000353	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	3.24e-05	0.000348	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	3.22e-05	0.000346	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—NCOR1—malignant glioma	3.17e-05	0.00034	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—BCAN—malignant glioma	3.15e-05	0.000338	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—BCHE—malignant glioma	3.13e-05	0.000336	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	3.12e-05	0.000335	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.1e-05	0.000333	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—SLC5A5—malignant glioma	3.09e-05	0.000332	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—CYP2B6—malignant glioma	3.09e-05	0.000332	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.95e-05	0.000317	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.85e-05	0.000306	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—IDH1—malignant glioma	2.82e-05	0.000303	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—GSTT1—malignant glioma	2.78e-05	0.000298	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—SPHK1—malignant glioma	2.73e-05	0.000293	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—GSTT1—malignant glioma	2.71e-05	0.000291	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—CYP2C18—malignant glioma	2.68e-05	0.000288	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	2.63e-05	0.000283	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—PTGS1—malignant glioma	2.6e-05	0.00028	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.6e-05	0.000279	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—CAV1—malignant glioma	2.58e-05	0.000277	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—PTGS1—malignant glioma	2.54e-05	0.000273	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—IDH2—malignant glioma	2.54e-05	0.000272	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.53e-05	0.000271	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—GSTP1—malignant glioma	2.49e-05	0.000268	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—CAT—malignant glioma	2.43e-05	0.00026	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—BCHE—malignant glioma	2.42e-05	0.00026	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—SLC5A5—malignant glioma	2.39e-05	0.000257	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—CYP2B6—malignant glioma	2.38e-05	0.000256	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—BCHE—malignant glioma	2.36e-05	0.000254	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—PIK3CG—malignant glioma	2.35e-05	0.000253	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—SLC5A5—malignant glioma	2.33e-05	0.000251	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.3e-05	0.000247	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—NCOR1—malignant glioma	2.29e-05	0.000246	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—PPARG—malignant glioma	2.27e-05	0.000244	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.26e-05	0.000243	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.24e-05	0.000241	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.22e-05	0.000238	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—IDH1—malignant glioma	2.18e-05	0.000234	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—GSTT1—malignant glioma	2.17e-05	0.000233	CbGpPWpGaD
Clarithromycin—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	2.15e-05	0.000231	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—SPHK1—malignant glioma	2.11e-05	0.000226	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—PIK3CD—malignant glioma	2.07e-05	0.000222	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—CYP2C18—malignant glioma	2.07e-05	0.000222	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—PTGS1—malignant glioma	2.03e-05	0.000218	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.02e-05	0.000217	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.95e-05	0.00021	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—GSTP1—malignant glioma	1.93e-05	0.000207	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—BCHE—malignant glioma	1.89e-05	0.000203	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—GSTP1—malignant glioma	1.88e-05	0.000202	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—CAT—malignant glioma	1.87e-05	0.000201	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—CAV1—malignant glioma	1.87e-05	0.0002	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—SLC5A5—malignant glioma	1.86e-05	0.0002	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—CAT—malignant glioma	1.83e-05	0.000196	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—PIK3CB—malignant glioma	1.8e-05	0.000194	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—PTGS2—malignant glioma	1.79e-05	0.000192	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—NCOR1—malignant glioma	1.77e-05	0.00019	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.76e-05	0.000189	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.75e-05	0.000187	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—NCOR1—malignant glioma	1.73e-05	0.000186	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—PIK3CG—malignant glioma	1.7e-05	0.000183	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—GSTT1—malignant glioma	1.67e-05	0.000179	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—PPARG—malignant glioma	1.64e-05	0.000176	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—PTGS1—malignant glioma	1.57e-05	0.000168	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—PTEN—malignant glioma	1.56e-05	0.000167	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.52e-05	0.000164	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—GSTP1—malignant glioma	1.5e-05	0.000161	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—PIK3CD—malignant glioma	1.49e-05	0.00016	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—CAT—malignant glioma	1.46e-05	0.000157	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—BCHE—malignant glioma	1.46e-05	0.000156	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—CAV1—malignant glioma	1.44e-05	0.000155	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—SLC5A5—malignant glioma	1.44e-05	0.000154	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—CAV1—malignant glioma	1.41e-05	0.000151	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—NCOR1—malignant glioma	1.38e-05	0.000148	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.38e-05	0.000148	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—PIK3CG—malignant glioma	1.31e-05	0.000141	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—PIK3CB—malignant glioma	1.3e-05	0.00014	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—PTGS2—malignant glioma	1.29e-05	0.000139	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—PIK3CG—malignant glioma	1.28e-05	0.000138	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—PPARG—malignant glioma	1.27e-05	0.000136	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—PPARG—malignant glioma	1.24e-05	0.000133	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—GSTP1—malignant glioma	1.16e-05	0.000124	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—PIK3CD—malignant glioma	1.16e-05	0.000124	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—PIK3CD—malignant glioma	1.13e-05	0.000121	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—CAT—malignant glioma	1.13e-05	0.000121	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—PTEN—malignant glioma	1.13e-05	0.000121	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—CAV1—malignant glioma	1.12e-05	0.000121	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—PIK3CA—malignant glioma	1.1e-05	0.000118	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.07e-05	0.000115	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—NCOR1—malignant glioma	1.06e-05	0.000114	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—PIK3CG—malignant glioma	1.02e-05	0.00011	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—PIK3CB—malignant glioma	1.01e-05	0.000108	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—PTGS2—malignant glioma	9.98e-06	0.000107	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—PPARG—malignant glioma	9.89e-06	0.000106	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—PIK3CB—malignant glioma	9.83e-06	0.000106	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—PTGS2—malignant glioma	9.74e-06	0.000105	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—PIK3CD—malignant glioma	9.01e-06	9.67e-05	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—AKT1—malignant glioma	8.98e-06	9.64e-05	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—PTEN—malignant glioma	8.71e-06	9.35e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—CAV1—malignant glioma	8.68e-06	9.32e-05	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—PTEN—malignant glioma	8.5e-06	9.12e-05	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—PIK3CA—malignant glioma	7.94e-06	8.53e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—PIK3CG—malignant glioma	7.91e-06	8.49e-05	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—PIK3CB—malignant glioma	7.85e-06	8.43e-05	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—PTGS2—malignant glioma	7.78e-06	8.35e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—PPARG—malignant glioma	7.63e-06	8.19e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—PIK3CD—malignant glioma	6.95e-06	7.46e-05	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—PTEN—malignant glioma	6.78e-06	7.28e-05	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—AKT1—malignant glioma	6.49e-06	6.97e-05	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—PIK3CA—malignant glioma	6.14e-06	6.59e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—PIK3CB—malignant glioma	6.06e-06	6.5e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—PTGS2—malignant glioma	6e-06	6.44e-05	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—PIK3CA—malignant glioma	5.99e-06	6.43e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—PTEN—malignant glioma	5.23e-06	5.62e-05	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—AKT1—malignant glioma	5.02e-06	5.39e-05	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—AKT1—malignant glioma	4.9e-06	5.26e-05	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—PIK3CA—malignant glioma	4.79e-06	5.14e-05	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—AKT1—malignant glioma	3.91e-06	4.2e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—PIK3CA—malignant glioma	3.69e-06	3.96e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—AKT1—malignant glioma	3.02e-06	3.24e-05	CbGpPWpGaD
